We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$429M |
| 2 |
Airbnb
ABNB
|
+$235M |
| 3 |
T-Mobile US
TMUS
|
+$156M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$139M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$488M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$222M |
| 3 |
Expeditors International
EXPD
|
+$191M |
| 4 |
Qualcomm
QCOM
|
+$187M |
| 5 |
CERN
Cerner Corp
CERN
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Wynn Resorts
WYNN
$10.5B
| $457K | ﹤0.01% |
+3,735
| New | +$476K |
|
477
Gilead Sciences
GILD
$165B
| $404K | ﹤0.01% |
5,862
-24,762
| -81% | -$1.65M |
|
478
Adobe
ADBE
$108B
| $337K | ﹤0.01% |
575
-135
| -19% | -$69.6K |
|
479
Netflix
NFLX
$314B
| $309K | ﹤0.01% |
5,850
+50
| +0.9% | +$2.56K |
|
480
ServiceNow
NOW
$132B
| $265K | ﹤0.01% |
2,415
+15
| +0.6% | +$1.52K |
|
481
Carnival Corporation Ltd
CCL
$38.4B
| $250K | ﹤0.01% |
9,487
+8,728
| +1,150% | +$244K |
|
482
Artisan Partners
APAM
$3B
| $247K | ﹤0.01% |
4,872
-24,151
| -83% | -$1.27M |
|
483
Norwegian Cruise Line
NCLH
$8.55B
| $239K | ﹤0.01% |
+8,141
| New | +$245K |
|
484
Advanced Micro Devices
AMD
$775B
| $229K | ﹤0.01% |
2,440
-519
| -18% | -$41.9K |
|
|
SCHW
485
Charles Schwab
SCHW
$189B
| $207K | ﹤0.01% |
2,845
-24,061
| -89% | -$1.7M |
|
486
Etsy
ETSY
$7.52B
| $194K | ﹤0.01% |
942
-73
| -7% | -$13.5K |
|
487
Zoom
ZM
$31.4B
| $193K | ﹤0.01% |
498
-32
| -6% | -$10.7K |
|
488
Moderna
MRNA
$23.8B
| $192K | ﹤0.01% |
818
-68
| -8% | -$12.2K |
|
489
Fortinet
FTNT
$121B
| $184K | ﹤0.01% |
3,860
-855
| -18% | -$36.5K |
|
490
Kroger
KR
$34.7B
| $177K | ﹤0.01% |
4,612
-64
| -1% | -$2.41K |
|
491
Corteva
CTVA
$51.2B
| $170K | ﹤0.01% |
3,838
-291
| -7% | -$13.4K |
|
|
MGP
492
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $169K | ﹤0.01% |
4,617
| – | – |
|
493
CrowdStrike
CRWD
$230B
| $163K | ﹤0.01% |
2,592
-260
| -9% | -$14K |
|
494
Knight Transportation
KNX
$11.2B
| $161K | ﹤0.01% |
3,544
+202
| +6% | +$9.65K |
|
|
LNW
495
DELISTED
Light & Wonder
LNW
| $161K | ﹤0.01% |
+2,083
| New | +$128K |
|
496
Humana
HUM
$46.5B
| $160K | ﹤0.01% |
361
-2,984
| -89% | -$1.3M |
|
497
Masco
MAS
$14.8B
| $156K | ﹤0.01% |
2,646
-26,025
| -91% | -$1.6M |
|
498
McKesson
MCK
$103B
| $155K | ﹤0.01% |
808
-306
| -27% | -$59.1K |
|
499
Synopsys
SNPS
$79.6B
| $153K | ﹤0.01% |
555
-189
| -25% | -$48K |
|
500
Lennox International
LII
$14.6B
| $152K | ﹤0.01% |
434
-149
| -26% | -$50.3K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
- Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
- Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
- Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
- Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
- Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.